A dedicated cardioversion unit for the treatment of atrial fibrillation. Reducing costs by optimizing processes

C Knackstedt1, M Becker, K Mischke

  • 1Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands.

Herz
|November 19, 2011
PubMed

Insights

Optimizing workflows for atrial fibrillation (AF) patients undergoing transesophageal echocardiography (TEE) and electrical cardioversion (ECV) significantly reduced procedure times and costs by over 50%. This streamlined approach enhances outpatient care efficiency.

Area of Science:

  • Cardiology
  • Medical Workflow Optimization
  • Health Economics

Background:

  • Atrial fibrillation (AF) is a prevalent cardiac arrhythmia requiring interventions like transesophageal echocardiography (TEE) for thrombus exclusion and electrical cardioversion (ECV) to restore sinus rhythm.
  • Patients often undergo these procedures with hospital admission, impacting resource utilization and costs.
  • This study focuses on optimizing the workflow for AF patients undergoing ECV in an outpatient setting.

Purpose of the Study:

  • To prospectively evaluate the impact of workflow optimization on procedural time and costs for AF patients undergoing ECV.
  • To assess the effectiveness of establishing a dedicated cardioversion unit (CU) for streamlining TEE and ECV procedures.
  • To identify key factors contributing to time and cost reductions in outpatient AF management.

Main Methods:

  • A dedicated cardioversion unit (CU) was established to centralize ECV-related procedures.
  • Three settings were compared: usual care, optimized process 1 (TEE+ECV in one sedation), and optimized process 2 (TEE+ECV with point-of-care blood testing).
  • Procedural time and all associated costs (material, human resources, infrastructure) were meticulously recorded and analyzed for 115 AF patients.

Main Results:

  • Procedural time decreased significantly from 480±105 minutes in the usual care setting to 205±85 minutes in the optimized process 2 setting (p < 0.001).
  • ECV-associated costs were substantially reduced from 683±104 € to 299±63 € (p < 0.001).
  • The combined TEE and ECV in a single sedation, along with point-of-care testing within the CU, were identified as primary drivers of efficiency gains.

Conclusions:

  • Establishing a specialized cardioversion unit (CU) can achieve over 50% reduction in procedural time and costs for AF patients.
  • Integrating transesophageal echocardiography (TEE) and electrical cardioversion (ECV) under a single sedation event is a key optimization strategy.
  • Point-of-care (POC) blood testing within the CU further contributes to significant time and cost savings, enhancing outpatient AF management.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.